Eli Lilly acquires Kelonia Therapeutics for $3,250M (June 2026)

Eli Lilly completed its acquisition of Kelonia Therapeutics on 25 June 2026 (Lilly Form 10-Q for the quarter ended 30 June 2026). Upfront consideration was $3,250M.

Source: https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm